Clinical Trial Results:
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Fixed-
Dose Study Evaluating the Effect of One Dose of Rimonabant (20 mg/day) on Glycemic Control in Type 2 Diabetic Patients Inadequately Controlled with Insulin
Summary
|
|
EudraCT number |
2005-001613-17 |
Trial protocol |
GB DE IT |
Global completion date |
20 Jul 2007
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
30 Apr 2016
|
First version publication date |
30 Apr 2016
|
Other versions |
|
Summary report(s) |
EFC5593 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.